Exozymes (EXOZ) Cash & Equivalents (2023 - 2024)
Exozymes (EXOZ) has disclosed Cash & Equivalents for 2 consecutive years, with $233935.0 as the latest value for Q3 2024.
- Quarterly Cash & Equivalents changed N/A to $233935.0 in Q3 2024 from the year-ago period, while the trailing twelve-month figure was $233935.0 through Sep 2024, changed N/A year-over-year, with the annual reading at $66533.0 for FY2023, N/A changed from the prior year.
- Cash & Equivalents for Q3 2024 was $233935.0 at Exozymes, up from $66533.0 in the prior quarter.
- The five-year high for Cash & Equivalents was $233935.0 in Q3 2024, with the low at $66533.0 in Q4 2023.